Hosted on MSN

IDEAYA Biosciences, Inc. (IDYA) enrolls first patient in phase 1 trial of IDE034 bispecific ADC

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) is among the 10 Fastest Growing NASDAQ Stocks to Buy. On February 25, 2026, IDEAYA Biosciences, Inc. (NASDAQ:IDYA) announced that the first patient has been ...
Microsoft

The shift reshaping enterprise applications

I recently sat down with Daniel Newman, CEO and principal analyst at Futurum to talk about where enterprise applications are headed next. We covered agents, automation, trust, and governance, but the ...